BNR
Burning Rock BiotechFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade F from latest DB weights. Momentum 22.7 / Value 41.9
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-06-04.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
23
Value
42
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Earnings
2026-06-04
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Why
Momentum23 · Δ7d -
Value42 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
23
52% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
42
48% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 22.7 / Value 41.9
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$101.4M
Beta
1.32
Shares Out
107.61M
P/E (TTM) · Derived
-0.2
P/S (TTM)
3.41
P/FCF (TTM) · Derived
-2.23
Rev YoY
+2.3%
EPS YoY
+55.1%
Gross Margin
+73.0%
Op Margin
-23.1%
Net Debt
-$73.11M
Current Ratio
3.14
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology